Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 19, 2025The Pediatric Infectious Disease Journal

Epidemiology and Clinical Impact of Mycoplasma pneumoniae in an Italian Pediatric Center: An Observational Study from 2017 to 2024

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMarco BianchiMPMara PisaniLRLara Ricotta

Discussion

Loading...

Member takes

Overview

Observational study analyzed trends of mycoplasma pneumoniae in hospitalized pediatric patients, highlighting increased incidence post-COVID-19.

Key Points

  • Mycoplasma pneumoniae incidence significantly increased post-pandemic, indicating emerging patterns in pediatric infections.
  • Among 303 patients, hospitalization rates for mycoplasma pneumoniae increased from 3.2% in 2019 to 6.1% in 2024, reflecting a notable resurgence.
  • Retrospective, single-center analysis utilized clinical and laboratory data to compare trends across pre-pandemic, pandemic, and post-pandemic periods.
  • Similar clinical severity post-pandemic highlights the need for ongoing epidemiologic surveillance to inform clinical management strategies.

Cite This Study

Bianchi et al. (2025) studied this question.

synapsesocial.com/papers/68d435ed713b0b5dfea75e40https://doi.org/10.1097/inf.0000000000004993
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evolving clinical features of Mycoplasma pneumoniae infections following COVID-19 pandemic restrictions: a retrospective, comparative cohort study2025
  2. 2Prevalence of Macrolide-Resistant Mycoplasma pneumoniae Infections After the COVID-19 Pandemic in Southern Italy, 2023–20252025
  3. 3Changes in <i>Mycoplasma pneumoniae</i> epidemiological and clinical features in children before, during, and after the COVID-19 pandemic in Shanghai, China2025 · 5 citations
  4. 4Mycoplasma pneumoniae Pneumonia: Variety of Presentation in Children Case Series2025
  5. 5Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities2025